-
Document de presse | 2024.02.14
Smoking has long-term effects on the immune system
Like other factors such as age, sex and genetics, smoking has a major impact on immune responses. This is the finding recently made by a team of scientists at the Institut Pasteur using the Milieu Intérieur cohort of 1,000 healthy volunteers, established to understand variability in immune responses. In addition to its short-term impact on immunity, smoking also has long-term consequences. For...
-
Page avancée | 2024.02.06
Our international cooperation
The Department of International Affairs develops institutional and scientific partnerships to boost the Institut Pasteur's global presence and tackle human health challenges.
-
News | 2024.02.06
Women and Girls in Science: find out more about seven of the Institut Pasteur's female scientists
To mark the 2024 edition of the International Day of Women and Girls in Science, we are proud to present the profiles of seven women working at the Institut Pasteur. PhD students, research unit heads, group leaders and clinicians, tackling tick-borne diseases, endometriosis, fungal infections, tuberculosis, breast cancer and brain tumors. These experts in immunology, genomics and medical...
-
Document de presse | 2024.02.08
Mariana Mesel-Lemoine appointed as Director of Diversity, Equity and Inclusion at the Institut Pasteur
Acting on a proposal from the Institut Pasteur President Yasmine Belkaid, the Institut Pasteur Board of Governors appointed Mariana Mesel-Lemoine as Director of Diversity, Equity and Inclusion on Wednesday February 7, 2024.This appointment marks a significant milestone in the history of the Institut Pasteur, and it is the first French research institute to establish a position of this kind at...
-
Document de presse | 2024.02.22
New epidemiological surveillance indicators for more effective monitoring of suicide attempts
Teams from the Child and Adolescent Psychiatry Department at Robert Debré Hospital (AP-HP), the AP-HP Digital Services Department and the Institut Pasteur, coordinated by Romain Bey and Prof. Richard Delorme, have developed novel digital tools to improve mental health monitoring for people living in the Greater Paris region. The data in this retrospective study were generated by analyzing several...
-
Article | 2024.02.27
Improving the Detection of Primary Immune Deficiency Diseases for Better Treatment
Primary Immune Deficiency diseases (PIDs) constitute a heterogeneous group of over 300 diseases in which a genetic defect of the immune system leads to an increased susceptibility to infections, sometimes jeopardizing the vital prognosis. The lack of awareness among the medical community about these diseases results in them remaining significantly underdiagnosed, both in children and in milder...
-
Document de presse | 2023.11.20
Study sheds light on evolution of brain folding in cerebellum of mammals
Researchers from the Institut Pasteur have compared the structure of the cerebellum and cerebrum in the brains of 56 mammals, providing insights into the evolution and mechanisms of brain folding.Scientists from the Institut Pasteur have characterised the folding of the cerebellar cortex using data from a sample of 56 mammalian species, allowing them to study the diversity and evolution of...
-
Portrait | 2024.03.05
Carla Saleh, leading the fight against viruses and inequality
When Carla Saleh arrived in France from Argentina aged 25 as a young scientist, she didn't speak a word of French. She now leads her own research unit at the Institut Pasteur.Her goal is to make mosquitoes intolerant to viruses. She is passionate about science, determined to tackle all forms of inequality and discrimination, and always keen to encourage anyone – especially girls and women – with...
-
Report | 2024.03.12
COVID-19: which monoclonal antibodies should be used for vulnerable individuals?
Vaccination does not offer sufficient protection against severe forms of COVID-19 for people with a weakened immune system. For these individuals, monoclonal antibodies have long been the preferred therapeutic solution. But depending on the SARS-CoV-2 variant, the effectiveness of these treatments has fluctuated. Scientists have had to develop novel antibodies that are more effective while also...
-
Article | 2024.03.12
DIAGNOSTIC
DiagnosticFrançois Rieunier, Head of Diagnostic Innovation DevelopmentFrançois Rieunier joined the Technology Transfer and Industrial Partnership Department in 2023 as Head of Dianostic Innovation Development.After a PhD from the University of Montpellier, in Chemistry applied to Biology, François joined the Biological Development team at Sanofi Diagnostic Pasteur in Marnes la Coquette...
